

Tratamientos previos
Cabozantinib (N=330)
Everolimus (N=328)
Number of VEGFR TKIs, %
1
71
70
2 or more
29
30
VEGFR-TKI, %
Sunitinib
64
62
Pazopanib
44
41
Axitinib
16
17
Sorafenib
6
9
Other systemic therapy, %
Cytokines
12
16
PD-1/PD-L1 checkpoint inhibitors
*
5
4
Bevacizumab
2
3
Radiotherapy, %
33
33
Nephrectomy, %
86
85